Miravet Sorribes L, Montoliu Nebot J, Iradi Casal A, Carrera Hueso F, Arnedo Pena A
Rev Esp Salud Publica. 2023; 97.
PMID: 37325902
PMC: 10558110.
Florensa D, Mateo-Fornes J, Lopez Sorribes S, Torres Tuca A, Solsona F, Godoy P
JMIR Cancer. 2023; 9:e44695.
PMID: 37079353
PMC: 10160936.
DOI: 10.2196/44695.
Li X, Li M, Lv J, Liu J, Dong M, Xia C
Front Oncol. 2022; 12:843220.
PMID: 35600389
PMC: 9117620.
DOI: 10.3389/fonc.2022.843220.
Yu X, Luo Q, Hughes S, Wade S, Caruana M, Canfell K
BMJ Open. 2019; 9(8):e028497.
PMID: 31462469
PMC: 6720154.
DOI: 10.1136/bmjopen-2018-028497.
Galve-Calvo E, Gonzalez-Haba E, Gostkorzewicz J, Martinez I, Perez-Mitru A
Clinicoecon Outcomes Res. 2018; 10:773-790.
PMID: 30532569
PMC: 6241542.
DOI: 10.2147/CEOR.S178934.
Determining personalized treatment by gene expression profiling in metastatic breast carcinoma patients: a pilot study.
Sureda M, Rebollo J, Martinez-Navarro E, Fernandez-Morejon F, Farre J, Munoz V
Clin Transl Oncol. 2017; 20(6):785-793.
PMID: 29159791
DOI: 10.1007/s12094-017-1789-9.
Expression and Prognostic Value of Oestrogen Receptor Beta in Colorectal Cancer.
Perez-Ruiz E, Rueda A, Perez L, Rivas-Ruiz F, Torres E, de Luque V
Pathol Oncol Res. 2017; 24(4):871-879.
PMID: 28889324
DOI: 10.1007/s12253-017-0301-8.
Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.
Gabaldo Barrios X, Sarabia Meseguer M, Marin Vera M, Sanchez Bermudez A, Macias Cerrolaza J, Henarejos P
Fam Cancer. 2017; 16(4):477-489.
PMID: 28477318
DOI: 10.1007/s10689-017-9985-x.
Cancer incidence in Spain, 2015.
Galceran J, Ameijide A, Carulla M, Mateos A, Quiros J, Rojas D
Clin Transl Oncol. 2017; 19(7):799-825.
PMID: 28093701
DOI: 10.1007/s12094-016-1607-9.
Radiation Oncology Teaching Programmes as Part of the Undergraduate Degree in Medicine in Spanish Universities: the Need for an Update of the Contents and Structure.
Arenas M, Sabater S, Biete A, Lara P, Calvo F
J Cancer Educ. 2016; 33(2):352-358.
PMID: 27595996
DOI: 10.1007/s13187-016-1106-2.
Defining the optimal sequence for the systemic treatment of metastatic breast cancer.
Mestres J, iMolins A, Martinez L, Lopez-Muniz J, Gil E, de Juan Ferre A
Clin Transl Oncol. 2016; 19(2):149-161.
PMID: 27314861
PMC: 5239809.
DOI: 10.1007/s12094-016-1520-2.
Home management of acute medical complications in cancer patients: a prospective pilot study.
Font C, Fernandez-Aviles F, Calderon C, Garcia-Fernandez T, Arab N, Pineda E
Support Care Cancer. 2015; 24(5):2129-2137.
PMID: 26556209
DOI: 10.1007/s00520-015-3006-0.
Trends in lung cancer incidence by histologic subtype in the south of Spain, 1985-2012: a population-based study.
Linares I, Molina-Portillo E, Exposito J, Baeyens J, Suarez C, Sanchez M
Clin Transl Oncol. 2015; 18(5):489-96.
PMID: 26329296
DOI: 10.1007/s12094-015-1392-x.
Clinical intervals and diagnostic characteristics in a cohort of prostate cancer patients in Spain: a multicentre observational study.
Bonfill X, Martinez-Zapata M, Vernooij R, Sanchez M, Morales Suarez-Varela M, DE LA Cruz J
BMC Urol. 2015; 15:60.
PMID: 26134117
PMC: 4488131.
DOI: 10.1186/s12894-015-0058-x.
Circulating miR-200c and miR-141 and outcomes in patients with breast cancer.
Antolin S, Calvo L, Blanco-Calvo M, Santiago M, Lorenzo-Patino M, Haz-Conde M
BMC Cancer. 2015; 15:297.
PMID: 25885099
PMC: 4405843.
DOI: 10.1186/s12885-015-1238-5.
Trends in the surgical procedures of women with incident breast cancer in Catalonia, Spain, over a 7-year period (2005-2011).
Escriba J, Pareja L, Esteban L, Galvez J, Melia A, Roca L
BMC Res Notes. 2014; 7:587.
PMID: 25178360
PMC: 4165913.
DOI: 10.1186/1756-0500-7-587.
Implementation and assessment of a fast-track programme to improve communication between primary and specialized care in patients with suspected cancer: how to shorten time between initial symptoms of cancer, diagnosis and initiation of treatment.
Martinez M, Gonzalez I, Tarazona N, Rosello S, Saiz R, Sanmartin A
Clin Transl Oncol. 2014; 17(2):167-72.
PMID: 25100066
DOI: 10.1007/s12094-014-1209-3.
Evaluation of the interval cancer rate and its determinants on the Girona Health Region's early breast cancer detection program.
Renart-Vicens G, Puig-Vives M, Albanell J, Castaner F, Ferrer J, Carreras M
BMC Cancer. 2014; 14:558.
PMID: 25085350
PMC: 4129104.
DOI: 10.1186/1471-2407-14-558.
Time trends in municipal distribution patterns of cancer mortality in Spain.
Lopez-Abente G, Aragones N, Perez-Gomez B, Pollan M, Garcia-Perez J, Ramis R
BMC Cancer. 2014; 14:535.
PMID: 25060700
PMC: 4124154.
DOI: 10.1186/1471-2407-14-535.
Thymidylate synthase polymorphisms in genomic DNA as clinical outcome predictors in a European population of advanced non-small cell lung cancer patients receiving pemetrexed.
Arevalo E, Castanon E, Lopez I, Salgado J, Collado V, Santisteban M
J Transl Med. 2014; 12:98.
PMID: 24726028
PMC: 3996904.
DOI: 10.1186/1479-5876-12-98.